Intro

This chapter explores the obstacles a major medical technology company encounters due to increased trade barriers and tariffs, leading to a strategic pivot towards U.S. localization of production. It also examines the intricate dynamics of supply chains and the ongoing efforts to comply with regulatory standards in the health tech industry.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app